Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity

被引:393
作者
Salmena, L
Lemmers, B
Hakem, A
Matysiak-Zablocki, E
Murakami, K
Au, PYB
Berry, DM
Tamblyn, L
Shehabeldin, A
Migon, E
Wakeham, A
Bouchard, D
Yeh, WC
McGlade, JC
Ohashi, PS
Hakem, R [1 ]
机构
[1] Univ Toronto, AMDI, Toronto, ON M5G 2C1, Canada
[2] Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 2C1, Canada
[3] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada
[4] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumor Res Ctr, Toronto, ON M5G 1X8, Canada
关键词
caspase; 8; conditional mutation; T-cells; homeostasis; apoptosis; CD95;
D O I
10.1101/gad.1063703
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Defects in death receptor-mediated apoptosis have been linked to cancer and autoimmune disease in humans. The in vivo role of caspase 8, a component of this pathway, has eluded analysis in postnatal tissues because of the lack of an appropriate animal model. Targeted disruption of caspase 8 is lethal in utero. We generated mice with a targeted caspase 8 mutation that is restricted to the T-cell lineage. Despite normal thymocyte development in the absence of caspase 8, we observed a marked decrease in the number of peripheral T-cells and impaired T-cell response ex vivo to activation stimuli. caspase 8 ablation protected thymocytes and activated T-cells from CD95 ligand but not anti-CD3-induced apoptosis, or apoptosis activated by agents that are known to act through the mitochondria. caspase 8 mutant mice were unable to mount an immune response to viral infection, indicating that caspase 8 deletion in T-cells leads to immunodeficiency. These findings identify an essential, cell-stage-specific role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. This is consistent with the recent identification of caspase 8 mutations in human immunodeficiency.
引用
收藏
页码:883 / 895
页数:13
相关论文
共 72 条
[1]   Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells [J].
Alam, A ;
Cohen, LY ;
Aouad, S ;
Sékaly, RP .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (12) :1879-1890
[2]   Targeting death and decoy receptors of the tumour-necrosis factor superfamily [J].
Ashkenazi, A .
NATURE REVIEWS CANCER, 2002, 2 (06) :420-430
[3]   Defects in regulation of apoptosis in caspase-2-deficient mice [J].
Bergeron, L ;
Perez, GI ;
Macdonald, G ;
Shi, LF ;
Sun, Y ;
Jurisicova, A ;
Varmuza, S ;
Latham, KE ;
Flaws, JA ;
Salter, JCM ;
Hara, H ;
Moskowitz, MA ;
Li, E ;
Greenberg, A ;
Tilly, JL ;
Yuan, JY .
GENES & DEVELOPMENT, 1998, 12 (09) :1304-1314
[4]   Caspase-dependent cleavage of the hematopoietic specific adaptor protein Gads alters signalling from the T cell receptor [J].
Berry, DM ;
Benn, SJ ;
Cheng, AM ;
McGlade, CJ .
ONCOGENE, 2001, 20 (10) :1203-1211
[5]   Estimating the precursor frequency of naive antigen-specific CD8 T cells [J].
Blattman, JN ;
Antia, R ;
Sourdive, DJD ;
Wang, XC ;
Kaech, SM ;
Murali-Krishna, K ;
Altman, JD ;
Ahmed, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (05) :657-664
[6]   TRAIL receptor-2 signals apoptosis through FADD and caspase-8 [J].
Bodmer, JL ;
Holler, N ;
Reynard, S ;
Vinciguerra, P ;
Schneider, P ;
Juo, P ;
Blenis, J ;
Tschopp, J .
NATURE CELL BIOLOGY, 2000, 2 (04) :241-243
[7]   Proapoptotic Bcl-2 relative bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity [J].
Bouillet, P ;
Metcalf, D ;
Huang, DCS ;
Tarlinton, DM ;
Kay, TWH ;
Köntgen, F ;
Adams, JM ;
Strasser, A .
SCIENCE, 1999, 286 (5445) :1735-1738
[8]   BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes [J].
Bouillet, P ;
Purton, JF ;
Godfrey, DI ;
Zhang, LC ;
Coultas, L ;
Puthalakath, H ;
Pellegrini, M ;
Cory, S ;
Adams, JM ;
Strasser, A .
NATURE, 2002, 415 (6874) :922-926
[9]   Death receptors couple to both cell proliferation and apoptosis [J].
Budd, RC .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (04) :437-441
[10]   Activation-induced cell death [J].
Budd, RC .
CURRENT OPINION IN IMMUNOLOGY, 2001, 13 (03) :356-362